Danish-Taiwanese startup BluSense Diagnostics has developed a method with which it can detect both Dengue fever and the Zika virus very quickly. With just a little blood from the fingertip of the patient. If the system should be adopted by medical facilities, costs for patients and providers might plummet, as the BluSense tests are only $20 per person. BluSense Diagnostics is also collaborating with the FDA for their Zika test to be approved. The test for Dengue fever already has been.
Digital Trends
Why not share this article?
